206 related articles for article (PubMed ID: 17462818)
1. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells.
Shen Y; Cai M; Xia W; Liu J; Zhang Q; Xie H; Wang C; Wang X; Zheng S
Cancer Lett; 2007 Sep; 254(2):288-97. PubMed ID: 17462818
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and overadditive effects of rapamycin and FTY720 in pancreatic cancer cells in vitro.
Shen Y; Wang X; Xia W; Wang C; Cai M; Xie H; Zhou L; Zheng S
Transplant Proc; 2008 Jun; 40(5):1727-33. PubMed ID: 18589181
[TBL] [Abstract][Full Text] [Related]
3. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
[TBL] [Abstract][Full Text] [Related]
4. FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.
Zhou C; Ling MT; Kin-Wah Lee T; Man K; Wang X; Wong YC
Cancer Lett; 2006 Feb; 233(1):36-47. PubMed ID: 16473668
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
Azuma H; Takahara S; Horie S; Muto S; Otsuki Y; Katsuoka Y
J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800
[TBL] [Abstract][Full Text] [Related]
6. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity.
Azuma H; Horie S; Muto S; Otsuki Y; Matsumoto K; Morimoto J; Gotoh R; Okuyama A; Suzuki S; Katsuoka Y; Takahara S
Anticancer Res; 2003; 23(4):3183-93. PubMed ID: 12926052
[TBL] [Abstract][Full Text] [Related]
7. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models.
Azuma H; Takahara S; Ichimaru N; Wang JD; Itoh Y; Otsuki Y; Morimoto J; Fukui R; Hoshiga M; Ishihara T; Nonomura N; Suzuki S; Okuyama A; Katsuoka Y
Cancer Res; 2002 Mar; 62(5):1410-9. PubMed ID: 11888913
[TBL] [Abstract][Full Text] [Related]
8. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
[TBL] [Abstract][Full Text] [Related]
9. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
[TBL] [Abstract][Full Text] [Related]
11. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
[TBL] [Abstract][Full Text] [Related]
12. Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.
Chua CW; Chiu YT; Yuen HF; Chan KW; Man K; Wang X; Ling MT; Wong YC
Clin Cancer Res; 2009 Jul; 15(13):4322-35. PubMed ID: 19509141
[TBL] [Abstract][Full Text] [Related]
13. Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.
Ng KT; Man K; Ho JW; Sun CK; Lee TK; Zhao Y; Lo CM; Poon RT; Fan ST
Int J Oncol; 2007 Feb; 30(2):375-80. PubMed ID: 17203219
[TBL] [Abstract][Full Text] [Related]
14. FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells.
Sonoda Y; Yamamoto D; Sakurai S; Hasegawa M; Aizu-Yokota E; Momoi T; Kasahara T
Biochem Biophys Res Commun; 2001 Feb; 281(2):282-8. PubMed ID: 11181042
[TBL] [Abstract][Full Text] [Related]
15. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase.
Lau ST; Lin ZX; Liao Y; Zhao M; Cheng CH; Leung PS
Cancer Lett; 2009 Aug; 281(1):42-52. PubMed ID: 19286308
[TBL] [Abstract][Full Text] [Related]
16. Effect of FTY720 on apoptosis of smooth muscle cells.
Böhler T; Guillebaud J; Etienne L; Canivet C; Kamar N; Rostaing L; Thiers JC; Galvani S; Augé N; Salvayre R; Nègre-Salvayre A; Thomsen M
Transplant Proc; 2007 Oct; 39(8):2624-6. PubMed ID: 17954194
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in human pancreatic cancer cells induced by eicosapentaenoic acid.
Shirota T; Haji S; Yamasaki M; Iwasaki T; Hidaka T; Takeyama Y; Shiozaki H; Ohyanagi H
Nutrition; 2005 Oct; 21(10):1010-7. PubMed ID: 16157238
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
19. Evidence that FTY720 induces rat thymocyte apoptosis.
Isoyama N; Takai K; Tsuchida M; Matsumura M; Naito K
Transpl Immunol; 2006 Apr; 15(4):265-71. PubMed ID: 16635748
[TBL] [Abstract][Full Text] [Related]
20. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
Krump-Konvalinkova V; Chwalla I; Siess W
Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
